- Home
- NHI vs ALVO Comparison
NHI vs ALVO Comparison
Compare NHI & ALVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NHI
- ALVO
- Stock Information
- Founded
- NHI 1991
- ALVO 2013
- Country
- NHI United States
- ALVO Luxembourg
- Employees
- NHI N/A
- ALVO N/A
- Industry
- NHI Real Estate Investment Trusts
- ALVO Biotechnology: Pharmaceutical Preparations
- Sector
- NHI Real Estate
- ALVO Health Care
- Exchange
- NHI Nasdaq
- ALVO Nasdaq
- Market Cap
- NHI 3.1B
- ALVO 3.4B
- IPO Year
- NHI 1991
- ALVO N/A
- Fundamental
- Price
- NHI $69.35
- ALVO $13.27
- Analyst Decision
- NHI Buy
- ALVO Buy
- Analyst Count
- NHI 8
- ALVO 1
- Target Price
- NHI $73.00
- ALVO $18.00
- AVG Volume (30 Days)
- NHI 257.8K
- ALVO 184.6K
- Earning Date
- NHI 02-18-2025
- ALVO 11-13-2024
- Dividend Yield
- NHI 5.19%
- ALVO N/A
- EPS Growth
- NHI 19.94
- ALVO N/A
- EPS
- NHI 2.91
- ALVO N/A
- Revenue
- NHI $329,848,000.00
- ALVO $393,919,000.00
- Revenue This Year
- NHI N/A
- ALVO $398.12
- Revenue Next Year
- NHI $14.12
- ALVO $44.73
- P/E Ratio
- NHI $23.82
- ALVO N/A
- Revenue Growth
- NHI 6.05
- ALVO 517.92
- 52 Week Low
- NHI $51.59
- ALVO $9.15
- 52 Week High
- NHI $86.13
- ALVO $18.00
- Technical
- Relative Strength Index (RSI)
- NHI 46.77
- ALVO 62.47
- Support Level
- NHI $65.13
- ALVO $13.06
- Resistance Level
- NHI $69.55
- ALVO $13.50
- Average True Range (ATR)
- NHI 1.45
- ALVO 0.35
- MACD
- NHI 0.41
- ALVO 0.00
- Stochastic Oscillator
- NHI 93.26
- ALVO 64.17
About NHI National Health Investors Inc.
National Health Investors Inc is a housing and medical facility REIT. The company operates through two reportable segments i.e. Real Estate Investments and Senior Housing Operating Portfolio. The Real Estate Investments segment consists of real estate investments and leases, mortgages, and other notes receivables in independent living facilities, assisted living facilities, entrance-fee communities, senior living campuses, skilled nursing facilities, and a hospital. The SHOP segment is comprised of two ventures that own the operations of independent living facilities. The company's revenues are derived from rental income, mortgage and other notes receivable interest income, and resident fees and services.
About ALVO Alvotech
Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to proven treatments for various diseases.